Company intelligence / Profile preview
Chongqing Huapont Pharmaceutical Co., Ltd.
- Ownership
- Private
- Development stage
- Commercial
Overview
Chongqing Huapont Pharmaceutical has over two decades of experience as an innovative pharmaceutical manufacturer. It specializes in dermatology and anti-tuberculosis medicines but also covers respiratory, cardiovascular/cerebrovascular, oncology, systemic glucocorticoids and more. The company has numerous approved products—both APIs and finished dosage forms—and exports to over sixty countries. It operates two FDF factories and two API factories with advanced technology platforms for research/manufacturing. Subsidiary Shengchem provides CDMO services globally.
- Therapeutic areas
- OncologyEndocrinologyImmunologyDermatologyInfectious Diseases
- Modalities
- Small moleculesGene therapy
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Chongqing Huapont Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chongqing Huapont Pharmaceutical Co., Ltd..